KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gsk (GSK) Gross Margin (2016 - 2025)

Historic Gross Margin for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to 73.58%.

  • Gsk's Gross Margin rose 35000.0% to 73.58% in Q3 2025 from the same period last year, while for Sep 2025 it was 73.4%, marking a year-over-year increase of 11300.0%. This contributed to the annual value of 71.16% for FY2024, which is 6000.0% down from last year.
  • Gsk's Gross Margin amounted to 73.58% in Q3 2025, which was up 35000.0% from 72.89% recorded in Q2 2025.
  • Gsk's Gross Margin's 5-year high stood at 74.23% during Q1 2025, with a 5-year trough of 17.38% in Q4 2021.
  • For the 5-year period, Gsk's Gross Margin averaged around 67.94%, with its median value being 72.05% (2023).
  • Per our database at Business Quant, Gsk's Gross Margin plummeted by -463400bps in 2021 and then soared by 479700bps in 2022.
  • Over the past 5 years, Gsk's Gross Margin (Quarter) stood at 17.38% in 2021, then surged by 276bps to 65.34% in 2022, then grew by 11bps to 72.57% in 2023, then rose by 1bps to 73.16% in 2024, then rose by 1bps to 73.58% in 2025.
  • Its Gross Margin stands at 73.58% for Q3 2025, versus 72.89% for Q2 2025 and 74.23% for Q1 2025.